Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial.
BMJ open（2023）
摘要
ACTRN12622000978763.
更多查看译文
关键词
CARDIOLOGY,General diabetes,Nephrology,Transplant medicine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要